Pfizer shares data from experimental COVID-19 treatment with the FDA

CNN– Final data on Pfizer’s experimental treatment for COVID-19 has now been shared with the Food and Drug Administration. It’s part of the company’s application to authorize the pill for emergency use.

Mandy Gaither has a look at the results.